Research Study Validates Technology for Abuse Deterrent Prescription Drugs
PISGAH FOREST, N.C., Dec. 8, 2010 — Pisgah Labs announced today the findings from a proof of concept study confirming Pisgah’s technology imparts abuse deterrence to commonly abused prescription drugs, particularly narcotics. The controlled study, conducted in dogs, was performed wi…
MCFARLAND, Wis., July 28, 2010 — Pharmaplasia, a 180-page book, describes how pharmaceutical companies grew too fast, creating organizations that were too large to manage effectively and efficiently given the complexities of the business in an increasingly challenging healthcare market. A…
ISMPP Reiterates Progress in Medical Publications in Response to Senator Grassley’s Report
BRIARCLIFF MANOR, N.Y., July 19, 2010 — On June 24, 2010, the office of United States Senator Charles Grassley released a report entitled “Ghostwriting in Medical Literature” highlighting his concern “about the lack of transparency that exists in medical ghostwriting.&#…
‘Porcupine Pflu’: A Tale of Pandemic Proportions
PORTAGE, Mich., April 12, 2010 — The rumors appear to be true! The Hen 1 Pflu Virus is indeed spreading rapidly among the porcupine population, and the Big Pfarma Company must act quickly to contain it. Porcupine Pflu (published by Trafford Publishing), by George Hughes, is a clever parallel of the…
Pisgah Labs, Inc. Tackles Prescription Drug Abuse As It Files Eighth Patent
PISGAH FOREST, N.C., Jan. 12, 2010 — According to the Office of National Drug Control Policy (http://www.whitehousedrugpolicy.gov), prescription drug abuse is more prevalent than abuse of cocaine, heroin and methamphetamine. In fact, in the past year, prescription drug abuse ranked second…
Slumps in Pharmaceutical Profitability Tied to Insufficient Management Training
DELTA POINT, Inc.’s 2009 Leadership Skills Survey reveals the crucial relationship between gaps in sales management training and poor sales performance
SCOTTSDALE, Ariz., Oct. 14, 2009 — When it comes to slumping profitability in the current pharmaceutical sales industry, it is easy t…
MyClinicalTrial.com Launch Provides Solution to Online Healthcare and Clinical Trial Information
Provides No-Charge Trial Listing Service for Investigator Sites, Sponsors, CROs
GLEN BURNIE, Md., Sept. 23, 2009 — Clinical Site Services (CSS), a leader in patient enrollment solutions for the clinical research industry, announces the launch of its comprehensive website, http://www.MyCl…
Author’s Unwelcome Sequel Brings Light to Addiction
Richard McKenzie Neal chronicles the repetition of his son’s seemingly endless addiction to heroin
FOUNTAIN VALLEY, Calif., Feb. 18, 2009 — “The Path to Addiction … ‘and other troubles we are born to know’” (published by AuthorHouse) is a sequel that Ric…
JEFFERSON, N.C., Dec. 22, 2008 — Next Safety has developed a proprietary platform that delivers nicotine and a number of other drugs including albuterol and the components of Advair(TM), fluticasone propionate and salmeterol xinofoate, in air timed to the user’s inhalation. Certain US…
